Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

Short set configurations attenuate cardiovascular responses, reduce perceived exertion and allow for greater mechanical ...

HBAR price is still holding its recent rebound, but a key support near $0.140 now decides whether the move survives.

Abstract: The issue of fretting wear failure of electrical contacts in conductor-parallel groove clamp system might be brought on by breeze vibration. This study discusses the fretting wear behavior ...